Xvivo Perfusion AB (XVIPF)
22.81
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Xvivo Perfusion Market Cap : 718.53M for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Elekta AB | 2.226B |
| Getinge AB | 5.432B |
| Arjo AB | 807.58M |
| Paxman AB | 81.46M |
| Immunovia AB | 13.45M |
Market Cap Related Metrics
| PE Ratio | 90.48 |
| PS Ratio | 8.113 |
| Price to Book Value | 3.155 |
| Price to Free Cash Flow | 37.26 |
| Price | 22.81 |
| Earnings Yield | 1.11% |
| Operating PE Ratio | 72.38 |
| Normalized PE Ratio | 90.99 |